Cover art for podcast People Behind the Science Podcast - Stories from Scientists about Science, Life, Research, and Science Careers

People Behind the Science Podcast - Stories from Scientists about Science, Life, Research, and Science Careers

300 EpisodesProduced by Dr. Marie McNeely, featuring top scientists speaking about their life and cWebsite

Are you searching for great stories to ignite your curiosity, teach you to perform better in life and career, inspire your mind, and make you laugh along the way? In this science podcast, Dr. Marie McNeely introduces you to the brilliant researchers behind the latest scientific discoveries. Join us … read more

37:57

475: Designing Drugs to Decrease Damage in Healthy Tissue During Radiation Therapy Cancer Treatments - Dr. Dennis Riley

Dr. Dennis Riley is Co-Founder and Chief Scientific Officer at Galera Therapeutics, a clinical-stage biotech company discovering and developing innovative cancer treatments. He is also an Adjunct Professor of Chemistry at Washington University in St. Louis. Dennis and his colleagues have been developing synthetic enzymes that target undesired or toxic metabolic byproducts. One compound Dennis has developed protects healthy tissue from radiation damage during cancer treatment. When he’s not doing work, Dennis enjoys mountain biking, golfing, and amateur astronomy. He earned his Bachelor’s degree in chemistry and mathematics from Heidelberg College and his PhD in inorganic chemistry from The Ohio State University. Afterwards, Dennis conducted postdoctoral research at the University of Chicago. Dennis began his career working in research and development with Proctor and Gamble, and he spent much of his career working at Monsanto where he held the positions of Senior Science Fellow and Manager of Metal-Mediated Chemistry. He subsequently served as Vice President of Research at Metaphore Pharmaceuticals and Senior Vice-President at the start-up company Kereos before co-Founding Galera Therapeutics. Dennis is an elected Fellow of the American Association for the Advancement of Science and he has received the American Chemical Society St. Louis Section’s Chemist of the Year Award. In addition, Galera Therapeutics’ new drug GC4419 has been designated as a “Breakthrough Therapy” by the FDA for reduction in the duration, incidence, and severity of oral mucositis induced by radiation therapy in cancer patients. In this podcast interview, Dennis spoke with us about his experiences in life and science.

Educational emoji reaction

Educational

Interesting emoji reaction

Interesting

Funny emoji reaction

Funny

Agree emoji reaction

Agree

Love emoji reaction

Love

Wow emoji reaction

Wow

Are you the creator of this podcast?

Verify your account

and pick the featured episodes for your show.

Listen to People Behind the Science Podcast - Stories from Scientists about Science, Life, Research, and Science Careers

RadioPublic

A free podcast app for iPhone and Android

  • User-created playlists and collections
  • Download episodes while on WiFi to listen without using mobile data
  • Stream podcast episodes without waiting for a download
  • Queue episodes to create a personal continuous playlist
RadioPublic on iOS and Android
Or by RSS
RSS feed
https://peoplebehindthescience.libsyn.com/rss/

Connect with listeners

Podcasters use the RadioPublic listener relationship platform to build lasting connections with fans

Yes, let's begin connecting
Browser window

Find new listeners

  • A dedicated website for your podcast
  • Web embed players designed to convert visitors to listeners in the RadioPublic apps for iPhone and Android
Clicking mouse cursor

Understand your audience

  • Capture listener activity with affinity scores
  • Measure your promotional campaigns and integrate with Google and Facebook analytics
Graph of increasing value

Engage your fanbase

  • Deliver timely Calls To Action, including email acquistion for your mailing list
  • Share exactly the right moment in an episode via text, email, and social media
Icon of cellphone with money

Make money

  • Tip and transfer funds directly to podcastsers
  • Earn money for qualified plays in the RadioPublic apps with Paid Listens